| Stage | KVUE | % of rev | JNJ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.9B | 100.00% | $25.4B | 100.00% | JNJ ×6.54 |
| Gross profit | $2.3B | 59.55% | $17.3B | 68.12% | JNJ +8.6pp |
| Operating income | $706M | 18.17% | $5.8B | 23.01% | JNJ +4.8pp |
| Pre-tax income | $609M | 15.67% | $34M | 0.13% | KVUE +15.5pp |
| Net income | $430M | 11.07% | $210M | 0.83% | KVUE +10.2pp |
| Stage | KVUE | JNJ | Gap · A − B |
|---|---|---|---|
| Revenue | $3.9B100.00% | $25.4B100.00% | JNJ ×6.54 |
| Gross profit | 59.55%$2.3B | 68.12%$17.3B | JNJ +8.6pp |
| Operating income | 18.17%$706M | 23.01%$5.8B | JNJ +4.8pp |
| Pre-tax income | 15.67%$609M | 0.13%$34M | KVUE +15.5pp |
| Net income |
| 11.07%$430M |
| 0.83%$210M |
| KVUE +10.2pp |
None
No disclosed counterparties: KVUE.